{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:45Z","timestamp":1793314785329,"version":"4.5.0"},"reference-count":371,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY035312"],"award-info":[{"award-number":["R01EY035312"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY003146"],"award-info":[{"award-number":["P30EY003146"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY020318"],"award-info":[{"award-number":["R01EY020318"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000950","name":"The Alcon Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015112","name":"Melza M. and Frank Theodore Barr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.preteyeres.2026.101460","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:35:37Z","timestamp":1773826537000},"page":"101460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of prostanoids in the retina and optic nerve in health and disease"],"prefix":"10.1016","volume":"112","author":[{"given":"Emily","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Karnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amogh","family":"Changavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matangi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica A.","family":"Margeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Gronert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2026.101460_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0090-6980(77)90190-3","article-title":"Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain","volume":"14","author":"Abdel-Halim","year":"1977","journal-title":"Prostaglandins"},{"key":"10.1016\/j.preteyeres.2026.101460_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/pgs.15.6","article-title":"Pharmacogenomics of cyclooxygenases","volume":"16","author":"Agundez","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.preteyeres.2026.101460_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2005.10.068","article-title":"Prostaglandin EP4 receptor agonist protects against acute neurotoxicity","volume":"1066","author":"Ahmad","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11357-010-9135-y","article-title":"Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice","volume":"32","author":"Ahmad","year":"2010","journal-title":"Age"},{"key":"10.1016\/j.preteyeres.2026.101460_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.prostaglandins.2017.12.002","article-title":"Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway","volume":"134","author":"Ahn","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10384-021-00844-6","article-title":"Prostanoid receptor agonists for glaucoma treatment","volume":"65","author":"Aihara","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/IJG.0000000000001221","article-title":"Phase 2, randomized, dose-finding studies of omidenepag isopropyl, a selective EP2 agonist, in patients with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Aihara","year":"2019","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2026.101460_bib8","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/ph3061949","article-title":"Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions","volume":"3","author":"Ajmone-Cat","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2026.101460_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2023.1258734","article-title":"Lysolipids are prominent in subretinal drusenoid deposits, a high-risk phenotype in age-related macular degeneration","volume":"3","author":"Anderson","year":"2023","journal-title":"Front. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2009.04.003","article-title":"Emerging roles of PGE2 receptors in models of neurological disease","volume":"91","author":"Andreasson","year":"2010","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/jnc.13667","article-title":"Targeting innate immunity for neurodegenerative disorders of the central nervous system","volume":"138","author":"Andreasson","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.09.001","article-title":"Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity","volume":"95","author":"Anglada-Huguet","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.preteyeres.2026.101460_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12035-013-8556-x","article-title":"Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington's disease","volume":"49","author":"Anglada-Huguet","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMcp2102061","article-title":"Age-related macular degeneration","volume":"385","author":"Apte","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib17","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1074\/jbc.M506431200","article-title":"Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase","volume":"281","author":"Aritake","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015604","article-title":"Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses","volume":"5","author":"Arthur","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101460_bib19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/HYPERTENSIONAHA.119.13175","article-title":"Brain prostaglandin D2 increases neurogenic pressor activity and mean arterial pressure in angiotensin II-Salt hypertensive rats","volume":"74","author":"Asirvatham-Jeyaraj","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preteyeres.2026.101460_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101303","article-title":"The relationship between intraocular pressure and glaucoma: an evolving concept","volume":"103","author":"Asrani","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/02713680903477832","article-title":"Cyclooxygenase-2 expression in retinoblastoma: an immunohistochemical analysis","volume":"35","author":"Atchaneeyasakul","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/13543784.2013.794782","article-title":"Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial","volume":"22","author":"Augustin","year":"2013","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.preteyeres.2026.101460_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2024.02.010","article-title":"Omidenepag isopropyl versus timolol in patients with glaucoma or ocular hypertension: two randomized phase 3 trials (SPECTRUM 4 and 3)","volume":"263","author":"Bacharach","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-1119(95)00881-0","article-title":"Genomic structure and polymorphism of the human thromboxane synthase-encoding gene","volume":"173","author":"Baek","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.preteyeres.2026.101460_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1357-2725(03)00236-X","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) mediates efflux of bimane-glutathione","volume":"36","author":"Bai","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib26","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.95.14.7951","article-title":"Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2","volume":"95","author":"Balsinde","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0306-4522(91)90118-8","article-title":"Prostaglandin E2 changes in the retina and optic nerve of an eye with injured optic nerve","volume":"45","author":"Bar-Ilan","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2026.101460_bib28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1167\/iovs.09-3691","article-title":"Role of cytosolic phospholipase A(2) in retinal neovascularization","volume":"51","author":"Barnett","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib29","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1152\/jappl.2001.90.6.2279","article-title":"Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy","volume":"90","author":"Beauchamp","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.prostaglandins.2017.09.005","article-title":"Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development","volume":"134","author":"Beharry","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101460_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41590-023-01437-w","article-title":"Temporal single-cell atlas of non-neuronal retinal cells reveals dynamic, coordinated multicellular responses to central nervous system injury","volume":"24","author":"Benhar","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102235","article-title":"Deletion of the gene encoding prostamide\/prostaglandin F synthase reveals an important role in regulating intraocular pressure","volume":"165","author":"Bertrand","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.preteyeres.2026.101460_bib33","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/bjophthalmol-2020-317762","article-title":"The role of EP(2) receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1","volume":"105","author":"Bertrand","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib34","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1523\/JNEUROSCI.16-19-06119.1996","article-title":"Lipocalin-type prostaglandin D synthase (beta-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix","volume":"16","author":"Beuckmann","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E","article-title":"Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat","volume":"428","author":"Beuckmann","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.20179","article-title":"PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis","volume":"56","author":"Bilak","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.plefa.2004.03.021","article-title":"Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study","volume":"71","author":"Biswas","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.preteyeres.2026.101460_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-4835(84)90102-7","article-title":"Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds","volume":"38","author":"Bito","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib40","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1471-4159.2005.03480.x","article-title":"Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli","volume":"95","author":"Blais","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib41","first-page":"1705","article-title":"Recategorization of non-aspirin nonsteroidal anti-inflammatory drugs according to clinical relevance: abandoning the traditional NSAID terminology","volume":"37","author":"Bonnesen","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biocel.2003.08.006","article-title":"Prostanoids and prostanoid receptors in signal transduction","volume":"36","author":"Bos","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib43","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","article-title":"Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial","volume":"377","author":"Bousser","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2026.101460_bib44","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fphar.2012.00098","article-title":"The prostaglandin F synthase activity of the human aldose reductase AKR1B1 brings new lenses to look at pathologic conditions","volume":"3","author":"Bresson","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.preteyeres.2026.101460_bib46","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/S0039-6257(01)00213-2","article-title":"Mechanism of action of bimatoprost (Lumigan)","volume":"45","author":"Brubaker","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib47","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","year":"2011"},{"key":"10.1016\/j.preteyeres.2026.101460_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10557-008-6132-9","article-title":"Phospholipase A2 biochemistry","volume":"23","author":"Burke","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"Suppl. l","key":"10.1016\/j.preteyeres.2026.101460_bib49","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","article-title":"Phospholipase A2 structure\/function, mechanism, and signaling","volume":"50","author":"Burke","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-0716-3012-9_2","article-title":"Defining selective neuronal resilience and identifying targets of neuroprotection and axon regeneration using single-cell RNA sequencing: computational approaches","volume":"2636","author":"Butrus","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib51","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3559","article-title":"Optic nerve crush in mice to study retinal ganglion cell survival and regeneration","volume":"10","author":"Cameron","year":"2020","journal-title":"Bio Protoc."},{"key":"10.1016\/j.preteyeres.2026.101460_bib52","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/jnr.21425","article-title":"PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity","volume":"85","author":"Carrasco","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2008.05.111","article-title":"Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress","volume":"441","author":"Carrasco","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.preteyeres.2026.101460_bib54","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.2147\/OPTH.S224192","article-title":"Hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives","volume":"15","author":"Celebi","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000533404","article-title":"Documented reperfusion of the retina on fluorescein angiography after administration of intravenous prostaglandin E1 for central retinal artery occlusion: a case report","volume":"14","author":"Chacko","year":"2023","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.expneurol.2009.07.027","article-title":"Microsomal prostaglandin E synthase-2: cellular distribution and expression in alzheimer's disease","volume":"223","author":"Chaudhry","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jalz.2007.10.015","article-title":"Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease","volume":"4","author":"Chaudhry","year":"2008","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.preteyeres.2026.101460_bib58","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1152\/jn.2002.87.6.2851","article-title":"Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.09-5115","article-title":"Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse","volume":"52","author":"Chen","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.freeradbiomed.2017.11.016","article-title":"Targeting the 15-keto-PGE2-PTGR2 axis modulates systemic inflammation and survival in experimental sepsis","volume":"115","author":"Chen","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib61","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bjo.78.12.921","article-title":"Localisation of thromboxane A2 receptors and the corresponding mRNAs in human eye tissue","volume":"78","author":"Chen","year":"1994","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib62","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.21037\/atm-21-2717","article-title":"Prostaglandin F2alpha protects against pericyte apoptosis by inhibiting the PI3K\/Akt\/GSK3beta\/beta-catenin signaling pathway","volume":"9","author":"Cheng","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fncel.2018.00357","article-title":"The leptomeninges produce prostaglandin D(2) involved in sleep regulation in mice","volume":"12","author":"Cherasse","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib64","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s42003-022-04134-w","article-title":"Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats","volume":"5","author":"Chern","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/bjo.2005.080895","article-title":"Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension","volume":"90","author":"Chiba","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tips.2009.01.002","article-title":"The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research","volume":"30","author":"Choi","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib67","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1096\/fj.07-9411com","article-title":"Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury","volume":"22","author":"Choi","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib68","doi-asserted-by":"crossref","first-page":"11237","DOI":"10.1523\/JNEUROSCI.2836-09.2009","article-title":"Adenosine-evoked hyperpolarization of retinal ganglion cells is mediated by G-protein-coupled inwardly rectifying K+ and small conductance Ca2+-activated K+ channel activation","volume":"29","author":"Clark","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ph16060898","article-title":"Pharmacological approaches to modulate the scarring process after glaucoma surgery","volume":"16","author":"Collotta","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.preteyeres.2026.101460_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8362","article-title":"Suspected case of benign familial fleck retina with functional loss","volume":"11","author":"Constable","year":"2023","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib71","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.exer.2004.05.015","article-title":"Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions","volume":"79","author":"Cools-Lartigue","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00417-002-0469-8","article-title":"Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients","volume":"240","author":"Costagliola","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00254233","article-title":"Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formation","volume":"22","author":"Costantini","year":"1988","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.preteyeres.2026.101460_bib74","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.preteyeres.2026.101460_bib75","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1167\/iovs.04-0338","article-title":"Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor","volume":"45","author":"Crowston","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs","volume":"104","author":"Cryer","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/jcbfm.2013.9","article-title":"Prostaglandin E2, a postulated astrocyte-derived neurovascular coupling agent, constricts rather than dilates parenchymal arterioles","volume":"33","author":"Dabertrand","year":"2013","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib78","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/aos.15276","article-title":"The impact of topical NSAID treatment on selective laser trabeculoplasty efficacy","volume":"101","author":"Dahlgren","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib79","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","article-title":"Glaucoma: the retina and beyond","volume":"132","author":"Davis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.63.2.11","article-title":"Impact of next generation sequencing in unraveling the genetics of 1036 Spanish families with inherited macular dystrophies","volume":"63","author":"Del Pozo-Valero","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib81","first-page":"36","article-title":"Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina","volume":"26","author":"Deng","year":"2020","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2026.101460_bib82","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-7","article-title":"Phospholipase A2 in eicosanoid generation","volume":"161","author":"Dennis","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib83","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/0008-5472.CAN-24-1130","article-title":"GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling","volume":"85","author":"DeVito","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.preteyeres.2026.101460_bib84","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14656566.2017.1328498","article-title":"Topical treatment of glaucoma: established and emerging pharmacology","volume":"18","author":"Dikopf","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101460_bib85","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00417-003-0835-1","article-title":"The influence of latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study","volume":"242","author":"Dinslage","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib86","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1074\/jbc.M111.231969","article-title":"Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer","volume":"286","author":"Dong","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib87","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1167\/iovs.06-0823","article-title":"Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans","volume":"48","author":"Dorner","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1017557600233","article-title":"Human vitreal prostaglandin levels and proliferative diabetic retinopathy","volume":"103","author":"Douros","year":"2001","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.preteyeres.2026.101460_bib90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision","volume":"40","author":"Dumitrascu","year":"2020","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/exer.1999.0819","article-title":"Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines","volume":"70","author":"Dutkiewicz","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib92","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1097\/IAE.0b013e31822a042a","article-title":"Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema","volume":"31","author":"Elbendary","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101460_bib93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1538\/expanim.58.505","article-title":"Comparison of the protective effects of prostaglandin analogues in the ischemia and reperfusion model of rabbit eyes","volume":"58","author":"Emre","year":"2009","journal-title":"Exp. Anim."},{"key":"10.1016\/j.preteyeres.2026.101460_bib94","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10426","article-title":"Different chemical structures and physiological\/pathological roles of cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib95","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1038\/s41598-021-88690-x","article-title":"Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension","volume":"11","author":"Fang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anai.2013.06.031","article-title":"Lipid mediators and allergic diseases","volume":"111","author":"Fanning","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib97","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.eye.6703042","article-title":"Amfenac increases the radiosensitivity of uveal melanoma cell lines","volume":"22","author":"Fernandes","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2026.101460_bib98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-4182(03)80045-5","article-title":"Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours","volume":"38","author":"Figueiredo","year":"2003","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib99","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0090-6980(80)90126-4","article-title":"The stability of 13,14-dihydro-15 keto-PGE2","volume":"19","author":"Fitzpatrick","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1016\/j.preteyeres.2026.101460_bib100","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/bi00524a033","article-title":"Albumin-lipid interactions: prostaglandin stability as a probe for characterizing binding sites on vertebrate albumins","volume":"20","author":"Fitzpatrick","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.preteyeres.2026.101460_bib101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2026.101460_bib102","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/IAE.0000000000000403","article-title":"Topical nepafenec in eyes with noncentral diabetic macular edema","volume":"35","author":"Friedman","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101460_bib103","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.ajpath.2017.04.010","article-title":"Deficiency in EP4 receptor-associated protein ameliorates abnormal anxiety-like behavior and brain inflammation in a mouse model of alzheimer disease","volume":"187","author":"Fujikawa","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib104","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.preteyeres.2026.101460_bib105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12974-018-1198-1","article-title":"Inflammatory and cytotoxic effects of bifenthrin in primary microglia and organotypic hippocampal slice cultures","volume":"15","author":"Gargouri","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib106","first-page":"471","article-title":"Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits","volume":"32","author":"Goh","year":"1988","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114470","article-title":"Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway","volume":"9","author":"Gonzalez-Rodriguez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101460_bib108","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1538-7836.2007.02782.x","article-title":"Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers","volume":"5","author":"Graff","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.preteyeres.2026.101460_bib109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101460_bib110","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cpdd.1504","article-title":"Phase 1 mass balance study of pizuglanstat: an investigational hematopoietic prostaglandin D synthase inhibitor","volume":"14","author":"Hanada","year":"2025","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-025-02878-3","article-title":"Spatial mapping of the AA-PGE(2)-EP axis in multiple sclerosis lesions","volume":"149","author":"Hansen","year":"2025","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib113","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biochi.2010.02.007","article-title":"Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models","volume":"92","author":"Hara","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.preteyeres.2026.101460_bib114","first-page":"580","article-title":"Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins","volume":"35","author":"Hardy","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","article-title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Harirforoosh","year":"2009","journal-title":"Expet Opin. Drug Saf."},{"issue":"113","key":"10.1016\/j.preteyeres.2026.101460_bib116","first-page":"54065","article-title":"A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure","author":"Hartsock","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.preteyeres.2026.101460_bib117","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cmet.2023.03.006","article-title":"Molecular and metabolic heterogeneity of astrocytes and microglia","volume":"35","author":"Hasel","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.preteyeres.2026.101460_bib118","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI8338","article-title":"Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor","volume":"106","author":"Hata","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2026.101460_bib119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/107385840200800105","article-title":"Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives","volume":"8","author":"Hayaishi","year":"2002","journal-title":"Neuroscientist"},{"key":"10.1016\/j.preteyeres.2026.101460_bib120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9258(17)31235-8","article-title":"On the mechanism of prostacyclin and thromboxane A2 biosynthesis","volume":"264","author":"Hecker","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12035-009-8066-z","article-title":"Neuroinflammation and memory: the role of prostaglandins","volume":"40","author":"Hein","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib122","doi-asserted-by":"crossref","first-page":"27279","DOI":"10.1074\/jbc.M116.737353","article-title":"Spontaneous glutamatergic synaptic activity regulates constitutive COX-2 expression in neurons: OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 (STIMULATORY PROTEIN-1)","volume":"291","author":"Hewett","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib123","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26048-7","article-title":"Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection","volume":"12","author":"Hong","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100439","article-title":"Roles of lipocalin-type and hematopoietic prostaglandin D synthases in mouse retinal angiogenesis","volume":"64","author":"Horikami","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib126","doi-asserted-by":"crossref","first-page":"18493","DOI":"10.1074\/jbc.M109.003269","article-title":"Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor","volume":"284","author":"Hoshino","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113966","article-title":"Prostaglandin E2 in neuroblastoma: targeting synthesis or signaling?","volume":"156","author":"Hou","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101460_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111000","article-title":"Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma","volume":"39","author":"Hou","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib129","first-page":"369","article-title":"The effects of prostacyclin and its stable analog on intraocular pressure","volume":"312","author":"Hoyng","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib130","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00415-021-10838-6","article-title":"Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis","volume":"269","author":"Huang","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib131","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1471-4159.2005.03302.x","article-title":"Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production","volume":"94","author":"Ikeda-Matsuo","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2014.03.008","article-title":"PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease","volume":"112","author":"Illingworth","year":"2014","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib133","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1074\/jbc.M808593200","article-title":"Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase","volume":"284","author":"Irikura","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib134","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s11095-022-03329-4","article-title":"Lipocalin-type prostaglandin D(2) synthase Protein- A central player in metabolism","volume":"39","author":"Islam","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib135","first-page":"858","article-title":"Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina","volume":"43","author":"Ito","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib136","doi-asserted-by":"crossref","DOI":"10.3791\/53731","article-title":"A magnetic microbead occlusion model to induce ocular hypertension-dependent glaucoma in mice","author":"Ito","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.preteyeres.2026.101460_bib137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2008.10.003","article-title":"Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis","volume":"88","author":"Jania","year":"2009","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib138","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI77487","article-title":"Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models","volume":"125","author":"Johansson","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2026.101460_bib139","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cne.10400","article-title":"Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina","volume":"452","author":"Ju","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib140","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: cumulative meta-analysis","volume":"364","author":"Juni","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2026.101460_bib141","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/mp3007133","article-title":"Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery","volume":"10","author":"Kadam","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2026.101460_bib142","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.7754369","article-title":"Identification and characterization of a prostaglandin transporter","volume":"268","author":"Kanai","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2026.101460_bib143","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0092-8674(00)80374-8","article-title":"Cloning and crystal structure of hematopoietic prostaglandin D synthase","volume":"90","author":"Kanaoka","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2026.101460_bib144","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1046\/j.1432-1327.2000.01362.x","article-title":"Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase","volume":"267","author":"Kanaoka","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0952-3278(03)00077-2","article-title":"Hematopoietic prostaglandin D synthase","volume":"69","author":"Kanaoka","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.preteyeres.2026.101460_bib146","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1073\/pnas.0701585104","article-title":"Lipocalin-type prostaglandin D synthase\/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid","volume":"104","author":"Kanekiyo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib147","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-9394(99)00355-4","article-title":"Cox-2 expression in retinoblastoma","volume":"129","author":"Karim","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib148","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-024-01767-2","article-title":"Dysregulation of neuroprotective lipoxin pathway in astrocytes in response to cytokines and ocular hypertension","volume":"12","author":"Karnam","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib149","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain--an update","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.preteyeres.2026.101460_bib150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0197-0186(85)90063-4","article-title":"Comparison of prostanoid forming capacity of neuronal and astroglial cells in primary cultures","volume":"7","author":"Keller","year":"1985","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.preteyeres.2026.101460_bib151","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.2967\/jnumed.121.263199","article-title":"Cyclooxygenases as potential PET imaging biomarkers to explore neuroinflammation in dementia","volume":"63","author":"Kenou","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib152","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02713680600557030","article-title":"Differential expression of vitreous proteins in proliferative diabetic retinopathy","volume":"31","author":"Kim","year":"2006","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib153","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/10807680151125410","article-title":"Liposomal prostaglandin E1 enhances optic nerve head blood flow in cats","volume":"17","author":"Kitanishi","year":"2001","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.preteyeres.2026.101460_bib154","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: inos, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acn3.50978","article-title":"Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy","volume":"7","author":"Komaki","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib156","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuint.2017.06.013","article-title":"Pathophysiological role of prostaglandin E2-induced up-regulation of the EP2 receptor in motor neuron-like NSC-34 cells and lumbar motor neurons in ALS model mice","volume":"119","author":"Kosuge","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.preteyeres.2026.101460_bib157","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/awn008","article-title":"Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity","volume":"131","author":"Kotilinek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.preteyeres.2026.101460_bib158","article-title":"In Vivo brain imaging, biodistribution, and radiation dosimetry estimation of [(11)C]Celecoxib, a COX-2 PET ligand","volume":"23","author":"Kumar","year":"2018"},{"key":"10.1016\/j.preteyeres.2026.101460_bib159","first-page":"51","article-title":"Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR","volume":"8","author":"Kyveris","year":"2002","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2026.101460_bib160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.plefa.2004.11.006","article-title":"Prostaglandin E1 infusion therapy in dry age-related macular degeneration","volume":"72","author":"Ladewig","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.preteyeres.2026.101460_bib161","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/16000617.0067-2015","article-title":"Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension","volume":"24","author":"Lang","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib162","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0006-2952(99)00158-6","article-title":"Cyclooxygenase knockout mice: models for elucidating isoform-specific functions","volume":"58","author":"Langenbach","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib163","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1167\/iovs.13-12065","article-title":"Imaging the effects of prostaglandin analogues on cultured trabecular meshwork cells by coherent anti-stokes Raman scattering","volume":"54","author":"Lei","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib164","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fncel.2020.00109","article-title":"Longitudinal morphological and functional assessment of RGC neurodegeneration after optic nerve crush in mouse","volume":"14","author":"Li","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib165","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.12998\/wjcc.v7.i23.3915","article-title":"Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver","volume":"7","author":"Li","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.preteyeres.2026.101460_bib166","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21437","article-title":"The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis","volume":"64","author":"Liang","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib167","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","article-title":"Prostaglandin D2 mediates neuronal protection via the DP1 receptor","volume":"92","author":"Liang","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2007.07.002","article-title":"Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study","volume":"115","author":"Lim","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101460_bib169","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/946813","article-title":"Role of prostaglandins in neuroinflammatory and neurodegenerative diseases","volume":"2012","author":"Lima","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.preteyeres.2026.101460_bib170","article-title":"Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101460_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239233","article-title":"The influence of topical non-steroidal anti-inflammatory drugs on the intraocular pressure lowering effect of topical prostaglandin analogues-A systemic review and meta-analysis","volume":"15","author":"Lo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101460_bib172","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0090-6980(02)00028-X","article-title":"Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2","volume":"68\u201369","author":"Loftin","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2026.101460_bib173","first-page":"S232","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"Lucas","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib174","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100811","article-title":"A single-cell transcriptome atlas of the adult human retina","volume":"38","author":"Lukowski","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib175","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","article-title":"Management of central retinal artery occlusion: a scientific statement from the American heart association","volume":"52","author":"Mac Grory","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.preteyeres.2026.101460_bib176","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020388","article-title":"Astrocyte regulation of blood flow in the brain","volume":"7","author":"MacVicar","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib177","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2006.05.048","article-title":"Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease","volume":"1103","author":"Maida","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073396","article-title":"Dynamics of Cyclooxygenase-1 positive microglia\/macrophage in the retina of pathological model mice as a biomarker of the retinal inflammatory diseases","volume":"22","author":"Makabe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib179","first-page":"S5","article-title":"Intravenous prostaglandin E1 infusion for acute central retinal artery occlusion","volume":"50","author":"Malbin","year":"2019","journal-title":"Ophthalmic Surg. Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2026.101460_bib180","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","article-title":"Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma","volume":"55","author":"Margeta","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.preteyeres.2026.101460_bib181","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-3163-6-17","article-title":"The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production","volume":"6","author":"Marshall","year":"2007","journal-title":"J. Carcinog."},{"key":"10.1016\/j.preteyeres.2026.101460_bib182","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/carcin\/bgm091","article-title":"The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma","volume":"28","author":"Marshall","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.preteyeres.2026.101460_bib183","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","article-title":"Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs","volume":"62","author":"Martel-Pelletier","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2026.101460_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106815","article-title":"Lipid mediators in glaucoma: unraveling their diverse roles and untapped therapeutic potential","volume":"171","author":"Mathew","year":"2024","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib184","doi-asserted-by":"crossref","unstructured":"Mathew, D.J., Maurya, S., Ho, J., Livne-Bar, I., Chan, D., Zhang, J.W., Buys, Y.M., Sit, M., Trope, G., Peters, D.M., Flanagan, J.G., Gronert, K., Sivak, J.M., 2026. Lipidomic analysis reveals drug-induced lipoxin synthesis in glaucoma treatment. JCI Insight. 2026 Feb 24:e192010. doi: 10.1172\/jci.insight.192010. Epub ahead of print. PMID: 41734022.","DOI":"10.1172\/jci.insight.192010"},{"key":"10.1016\/j.preteyeres.2026.101460_bib186","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06759.x","article-title":"Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression","volume":"114","author":"Matousek","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib187","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1349-7006.2012.02200.x","article-title":"Thromboxane A(2) receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"103","author":"Matsui","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib188","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1126\/science.287.5460.2013","article-title":"Prostaglandin D2 as a mediator of allergic asthma","volume":"287","author":"Matsuoka","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2026.101460_bib189","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13024-024-00775-z","article-title":"Regulation of disease-associated microglia in the optic nerve by lipoxin B(4) and ocular hypertension","volume":"19","author":"Maurya","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.preteyeres.2026.101460_bib190","article-title":"Transcriptional and epigenetic regulation of microglia in maintenance of brain homeostasis and neurodegeneration","volume":"15","author":"Maurya","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib191","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib192","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","article-title":"Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia","volume":"24","author":"McCullough","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061440","article-title":"Approaches to potentiated neuroprotective treatment in the rodent model of ischemic optic neuropathy","volume":"10","author":"Mehrabian","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2026.101460_bib194","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1038\/s41598-021-83438-z","article-title":"Three-dimensional structure of human cyclooxygenase (hCOX)-1","volume":"11","author":"Miciaccia","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib195","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s12325-022-02069-6","article-title":"Efficacy and safety of omidenepag isopropyl 0.002% ophthalmic solution: a retrospective analysis of real-world data in Japan","volume":"39","author":"Miki","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2026.101460_bib196","first-page":"10","article-title":"Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy","volume":"3","author":"Mishra","year":"2011","journal-title":"Front. Neuroenerg."},{"key":"10.1016\/j.preteyeres.2026.101460_bib197","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1254\/jphs.11221FP","article-title":"Expression of microsomal prostaglandin E synthase-1 in the spinal cord in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"118","author":"Miyagishi","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib198","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306153120","article-title":"Transcriptomic analysis of the ocular posterior segment completes a cell atlas of the human eye","volume":"120","author":"Monavarfeshani","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101403","article-title":"Role of prostaglandins in nitric oxide-induced glial cell-mediated vasodilation in rat retina","volume":"12","author":"Mori","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.preteyeres.2026.101460_bib200","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1074\/jbc.M705638200","article-title":"Molecular characterization of a novel type of prostamide\/prostaglandin F synthase, belonging to the thioredoxin-like superfamily","volume":"283","author":"Moriuchi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib201","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2009.07.015","article-title":"A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension","volume":"104","author":"Mubarak","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib202","first-page":"424","article-title":"Localization of EP(1) and FP receptors in human ocular tissues by in situ hybridization","volume":"42","author":"Mukhopadhyay","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib203","doi-asserted-by":"crossref","first-page":"37937","DOI":"10.1074\/jbc.M305108200","article-title":"Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2","volume":"278","author":"Murakami","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib204","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0090-6980(02)00043-6","article-title":"Prostaglandin E synthase","volume":"68\u201369","author":"Murakami","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4049\/jimmunol.159.1.439","article-title":"Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2","volume":"159","author":"Murakami","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib206","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1074\/jbc.M114.587253","article-title":"Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system","volume":"290","author":"Muramatsu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib207","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1073\/pnas.0603235103","article-title":"15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis","volume":"103","author":"Myung","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/cells13201737","article-title":"L-PGDS-PGD2-DP1 axis regulates phagocytosis by CD36(+) MGs\/MPhis that are exclusively present within ischemic areas after stroke","volume":"13","author":"Nakagomi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2026.101460_bib209","first-page":"608","article-title":"In vivo effects of prostaglandins on human retinoblastoma cells in nude mice","volume":"31","author":"Nakamura","year":"1987","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2024.07.006","article-title":"Neuroprotective effect of omidenepag on excitotoxic retinal ganglion cell death regulating COX-2-EP2-cAMP-PKA\/Epac pathway via Neuron-Glia interaction","volume":"553","author":"Nakamura","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2026.101460_bib211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-017-0163-8","article-title":"Roles of organic anion transporting polypeptide 2A1 (OATP2A1\/SLCO2A1) in regulating the pathophysiological actions of prostaglandins","volume":"20","author":"Nakanishi","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2007.07.180","article-title":"Knockout mice lacking cPGES\/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal","volume":"362","author":"Nakatani","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib213","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40035-023-00366-w","article-title":"Update on the pathological roles of prostaglandin E(2) in neurodegeneration in amyotrophic lateral sclerosis","volume":"12","author":"Nango","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.preteyeres.2026.101460_bib214","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2183\/pjab.83.296","article-title":"Physiology and pathophysiology of prostanoid receptors","volume":"83","author":"Narumiya","year":"2007","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib215","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000266995","article-title":"Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment","volume":"22","author":"Naveh","year":"1990","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib217","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/etm.2016.3045","article-title":"Management of rheumatoid arthritis: impact and risks of various therapeutic approaches","volume":"11","author":"Negrei","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib218","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1006\/exer.1997.0394","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head","volume":"65","author":"Neufeld","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib219","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0195","article-title":"Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters","volume":"370","author":"Newman","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","article-title":"Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis","volume":"267","author":"Nie","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib221","first-page":"5103","article-title":"Transcriptional profiling analysis predicts potential biomarkers for glaucoma: HGF, AKR1B10 and AKR1C3","volume":"16","author":"Nie","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib222","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib223","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/db21-1072","article-title":"Prostaglandin PGE2 receptor EP4 regulates microglial phagocytosis and increases susceptibility to diet-induced obesity","volume":"72","author":"Niraula","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2026.101460_bib224","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1523\/JNEUROSCI.20-02-00763.2000","article-title":"Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex","volume":"20","author":"Niwa","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib225","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.65.4.973","article-title":"The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase","volume":"65","author":"Nomura","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib226","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1345\/aph.10133","article-title":"Celecoxib as adjunctive therapy for treatment of colorectal cancer","volume":"35","author":"North","year":"2001","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101460_bib227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.prostaglandins.2009.04.008","article-title":"Prostaglandin E2 synthases in neurologic homeostasis and disease","volume":"91","author":"O'Banion","year":"2010","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib228","first-page":"716","article-title":"Localization of the prostaglandin F2 alpha receptor messenger RNA and protein in the cynomolgus monkey eye","volume":"37","author":"Ocklind","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib229","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IJG.0000000000001836","article-title":"A randomized phase 2 trial comparing omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (SPECTRUM-6)","volume":"30","author":"Olander","year":"2021","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2026.101460_bib230","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.18632\/oncotarget.3581","article-title":"MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer","volume":"6","author":"Olesch","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.preteyeres.2026.101460_bib231","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1111\/bph.12815","article-title":"Multiple roles of the PGE2 -EP receptor signal in vascular permeability","volume":"171","author":"Omori","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib232","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2015.02.013","article-title":"CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice","volume":"284","author":"Onaka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib233","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1167\/iovs.08-3185","article-title":"Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia","volume":"50","author":"Osborne","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111220","article-title":"AKR1C2 and AKR1C3 expression in adipose tissue: association with body fat distribution and regulatory variants","volume":"527","author":"Ostinelli","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib235","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1523\/JNEUROSCI.0940-16.2016","article-title":"Selective vulnerability of specific retinal ganglion cell types and synapses after transient ocular hypertension","volume":"36","author":"Ou","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib236","doi-asserted-by":"crossref","unstructured":"Park, S.E., Hwang, J., Kang, N., Jung, J., Woo, H.M., Park, K.M., 2025. Effects of omidenepag isopropyl versus latanoprost eye drops on intraocular pressure, pupil diameter, and anterior chamber parameters in normal feline eyes: a pilot study. Vet. Ophthalmol.2026 Mar;29(2):e70078. doi: 10.1111\/vop.70078. Epub 2025 Oct 5. PMID: 41047758.","DOI":"10.1111\/vop.70078"},{"key":"10.1016\/j.preteyeres.2026.101460_bib237","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-199609050-00007","article-title":"Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension","volume":"9","author":"Patel","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.preteyeres.2026.101460_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1642986","article-title":"Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis","volume":"12","author":"Peng","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib239","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbrc.2018.01.188","article-title":"Plasma metabolic profile reveals PGF2alpha protecting against non-proliferative diabetic retinopathy in patients with type 2 diabetes","volume":"496","author":"Peng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203309360539","article-title":"Ocular side effects of anti-rheumatic medications: what a rheumatologist should know","volume":"19","author":"Peponis","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.preteyeres.2026.101460_bib241","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5301\/ejo.5000888","article-title":"Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study","volume":"27","author":"Pinna","year":"2017","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib242","first-page":"1336","article-title":"Metabolism of arachidonic acid in rabbit Iris and retina","volume":"26","author":"Preud'homme","year":"1985","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib243","article-title":"Imaging neuroinflammation - from bench to bedside","volume":"5","author":"Pulli","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib244","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcjo.2024.01.018","article-title":"Advancements in the diagnosis, prognosis, and treatment of retinoblastoma","volume":"59","author":"Rajput","year":"2024","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2026.101460_bib246","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/STROKEAHA.114.007470","article-title":"Effects of prostacyclin on cerebral blood flow and vasospasm after subarachnoid hemorrhage: randomized, pilot trial","volume":"46","author":"Rasmussen","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.preteyeres.2026.101460_bib247","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib248","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/bbrc.1999.1658","article-title":"Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells","volume":"265","author":"Reddy","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib249","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1081\/DMR-200047984","article-title":"Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5)","volume":"37","author":"Ritter","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2019.1554056","article-title":"The COX-2\/prostanoid signaling cascades in seizure disorders","volume":"23","author":"Rojas","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl. l","key":"10.1016\/j.preteyeres.2026.101460_bib252","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib253","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1167\/iovs.16-20425","article-title":"Topical treatment with bromfenac reduces retinal gliosis and inflammation after optic nerve crush","volume":"57","author":"Rovere","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib254","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biochi.2012.12.008","article-title":"A mouse model of in vivo chemical inhibition of retinal calcium-independent phospholipase A2 (iPLA2)","volume":"95","author":"Saab-Aoude","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.preteyeres.2026.101460_bib255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041227","article-title":"Extracellular vesicles as conveyors of membrane-derived bioactive lipids in immune system","volume":"19","author":"Sagini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib256","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1460-9568.2007.05627.x","article-title":"PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury","volume":"26","author":"Saleem","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib257","doi-asserted-by":"crossref","DOI":"10.3390\/vision7040072","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview","volume":"7","author":"Salvetat","year":"2023","journal-title":"Vision"},{"key":"10.1016\/j.preteyeres.2026.101460_bib258","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1523\/JNEUROSCI.2392-05.2005","article-title":"Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor","volume":"25","author":"Sang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib259","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","article-title":"The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina","volume":"24","author":"SanGiovanni","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib260","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2025.1665519","article-title":"Early prostaglandin E(1) treatment improves visual outcomes in central retinal artery occlusion: a retrospective study","volume":"5","author":"Sano","year":"2025","journal-title":"Front. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib261","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","article-title":"Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life","volume":"120","author":"Sapieha","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2026.101460_bib262","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1167\/iovs.09-3947","article-title":"The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice","volume":"51","author":"Sappington","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib263","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2008.10.094","article-title":"Prostaglandin D2 induces heme oxygenase-1 mRNA expression through the DP2 receptor","volume":"377","author":"Satarug","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib264","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2009.01.016","article-title":"Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor","volume":"217","author":"Savonenko","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib265","first-page":"1475","article-title":"Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues","volume":"43","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib266","article-title":"Nonsteroidal anti-inflammatory drugs for retinal disease","volume":"2013","author":"Schoenberger","year":"2013","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.preteyeres.2026.101460_bib267","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaophthalmol.2013.6203","article-title":"Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy","volume":"132","author":"Schoenberger","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib268","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.12-10410","article-title":"Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines","volume":"53","author":"Schoenberger","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib269","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jlb.66.4.535","article-title":"Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflammation","volume":"66","author":"Scott","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy","volume":"108","author":"Sennlaub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib271","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ajhg.2011.11.004","article-title":"Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina","volume":"89","author":"Sergouniotis","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2026.101460_bib272","doi-asserted-by":"crossref","unstructured":"Serhan, H.A., Oweidah, A., Shaheen, A., Emoush, L.O., Mahmoud, A.B., Al-Nawaflh, M., Elnahry, A.G., 2025. The efficacy and safety of intravenous prostaglandin E1 in the management of retinal artery occlusion: a systematic review. Retina. 2025 Mar 5. doi: 10.1097\/IAE.0000000000004458. Epub ahead of print. PMID: 40068212.","DOI":"10.1097\/IAE.0000000000004458"},{"key":"10.1016\/j.preteyeres.2026.101460_bib273","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1673-5374.343887","article-title":"Neuroaxonal and cellular damage\/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors","volume":"18","author":"Sharif","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109415","article-title":"FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma","volume":"229","author":"Sharif","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-9-14","article-title":"Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB\/cJ mice","volume":"9","author":"Sharma","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.preteyeres.2026.101460_bib276","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73809","article-title":"Diversification of multipotential postmitotic mouse retinal ganglion cell precursors into discrete types","volume":"11","author":"Shekhar","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.preteyeres.2026.101460_bib277","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/0113894501323980240815113851","article-title":"Prostaglandins in the inflamed central nervous system: potential therapeutic targets","volume":"25","author":"Sheremeta","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.preteyeres.2026.101460_bib278","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ophtha.2012.05.038","article-title":"Change in prostaglandin expression levels and synthesizing activities in dry eye disease","volume":"119","author":"Shim","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101460_bib279","doi-asserted-by":"crossref","first-page":"22141","DOI":"10.1074\/jbc.M109.084426","article-title":"A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules","volume":"285","author":"Shiraya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib280","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and regulation of cyclooxygenase-2 during inflammation","volume":"106","author":"Simon","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib281","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/11599230-000000000-00000","article-title":"Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever","volume":"72","author":"Smith","year":"2012","journal-title":"Drugs"},{"issue":"Suppl. l","key":"10.1016\/j.preteyeres.2026.101460_bib282","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib283","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.12.5.5","article-title":"Attenuation of laser-induced choroidal neovascularization by blockade of prostaglandin D2 receptor 2","volume":"12","author":"Soga","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib284","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1608376","article-title":"Prostaglandin E(2) stimulates opposing effects on inner and outer blood-retina barrier function","volume":"16","author":"Stark","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib286","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12974-024-03319-w","article-title":"Prostanoid signaling in retinal cells elicits inflammatory responses relevant to early-stage diabetic retinopathy","volume":"21","author":"Stark","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106864","article-title":"Prostanoid signaling in retinal vascular diseases","volume":"174","author":"Stark","year":"2024","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib288","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroimage.2006.03.014","article-title":"Modulatory role of cyclooxygenase-2 in cerebrovascular coupling","volume":"32","author":"Stefanovic","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.preteyeres.2026.101460_bib289","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/jps.2600661123","article-title":"Stability of prostaglandin E1 and dinoprostone (prostaglandin E2) under strongly acidic and basic conditions","volume":"66","author":"Stehle","year":"1977","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ICB.0b013e3182a48a04","article-title":"An ischemic diabetic eye treated with intravenous prostaglandin E1","volume":"8","author":"Steigerwalt","year":"2014","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib291","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0031-1278308","article-title":"Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids","volume":"17","author":"Steigerwalt","year":"2008","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib292","first-page":"119","article-title":"Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1","volume":"53","author":"Steigerwalt","year":"2011","journal-title":"Panminerva Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib293","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5582\/ddt.2016.01036","article-title":"Three episodes of non-arteritic posterior ischemic optic neuropathy in the same patient treated with intravenous prostaglandin E1","volume":"10","author":"Steigerwalt","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.preteyeres.2026.101460_bib294","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/000331970305400415","article-title":"Acute branch retinal arterial embolism successfully treated with intravenous prostaglandin E1--case reports","volume":"54","author":"Steigerwalt","year":"2003","journal-title":"Angiology"},{"key":"10.1016\/j.preteyeres.2026.101460_bib295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5582\/ddt.2017.01034","article-title":"Visual field improvement in non-arteritic posterior ischemic optic neuropathy in a patient treated with intravenous prostaglandin E1 and steroids","volume":"11","author":"Steigerwalt","year":"2017","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.preteyeres.2026.101460_bib296","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib297","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.82.3.367","article-title":"Changes in oxygen tension and effects on cyclooxygenase metabolites: III. Decrease of retinal prostacyclin in kittens exposed to hyperoxia","volume":"82","author":"Stuart","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2026.101460_bib298","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2017.05.067","article-title":"Identification of vitreous proteins in retinopathy of prematurity","volume":"488","author":"Sugioka","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib299","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/neup.12202","article-title":"Neuroaxonal dystrophy in PLA2G6 knockout mice","volume":"35","author":"Sumi-Akamaru","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.preteyeres.2026.101460_bib300","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112963","article-title":"Dynamic role of phospholipases A2 in health and diseases in the central nervous system","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2026.101460_bib301","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.plefa.2017.03.006","article-title":"Docosahexaenoic acid (DHA): an essential nutrient and a nutraceutical for brain health and diseases","volume":"136","author":"Sun","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.preteyeres.2026.101460_bib302","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jhep.2014.07.018","article-title":"mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2","volume":"61","author":"Sun","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib303","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-001014","article-title":"Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion","volume":"7","author":"Suzuki","year":"2022","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib304","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-5793(99)01551-3","article-title":"cDNA cloning, expression and characterization of human prostaglandin F synthase","volume":"462","author":"Suzuki-Yamamoto","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preteyeres.2026.101460_bib305","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/jnc.12018","article-title":"Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E(2) produced in the brain","volume":"123","author":"Tachikawa","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib306","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuint.2004.02.005","article-title":"Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons","volume":"45","author":"Takadera","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.preteyeres.2026.101460_bib307","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02449-1","article-title":"Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells","volume":"317","author":"Takadera","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.preteyeres.2026.101460_bib308","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1167\/iovs.12-11445","article-title":"Systemic prostaglandin E1 to treat acute central retinal artery occlusion","volume":"54","author":"Takai","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib309","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nn1623","article-title":"Astrocyte-mediated control of cerebral blood flow","volume":"9","author":"Takano","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jnr.22195","article-title":"Endothelial microsomal prostaglandin E synthase-1 exacerbates neuronal loss induced by kainate","volume":"88","author":"Takemiya","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib311","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/acn3.651","article-title":"A phase I study of TAS-205 in patients with Duchenne muscular dystrophy","volume":"5","author":"Takeshita","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib312","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.272.25.15789","article-title":"Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter","volume":"272","author":"Tanaka","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib313","doi-asserted-by":"crossref","unstructured":"Tang, Z., Zhang, S., Lee, C., Kumar, A., Arjunan, P., Li, Y., Zhang, F., Li, X., 2011. An optic nerve crush injury murine model to study retinal ganglion cell survival. J. Vis. Exp.2011 Apr 25;(50):2685.","DOI":"10.3791\/2685-v"},{"key":"10.1016\/j.preteyeres.2026.101460_bib314","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M003504200","article-title":"Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis","volume":"275","author":"Tanioka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1101\/lm.43602","article-title":"Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation","volume":"9","author":"Teather","year":"2002","journal-title":"Learn. Mem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib316","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100998","article-title":"Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets","volume":"87","author":"Tezel","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib317","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9394(01)00831-5","article-title":"Potential mechanism for the additivity of pilocarpine and latanoprost","volume":"131","author":"Toris","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib318","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/aos.12143","article-title":"Constriction of porcine retinal arterioles induced by endothelin-1 and the thromboxane analogue U46619 in vitro decreases with increasing vascular branching level","volume":"92","author":"Torring","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib319","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1167\/iovs.13-12055","article-title":"Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy","volume":"54","author":"Touitou","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib320","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","article-title":"Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes","volume":"104","author":"Tran","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2026.101460_bib321","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib322","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/intimm\/dxz021","article-title":"Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases","volume":"31","author":"Tsuge","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib323","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M100429200","article-title":"Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2","volume":"276","author":"Ueno","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib324","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2005.08.152","article-title":"Coupling between cyclooxygenases and terminal prostanoid synthases","volume":"338","author":"Ueno","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib325","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.smrv.2011.08.003","article-title":"Prostaglandin D2 and sleep\/wake regulation","volume":"15","author":"Urade","year":"2011","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.preteyeres.2026.101460_bib326","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib327","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jbior.2017.10.009","article-title":"Review of four major distinct types of human phospholipase A(2)","volume":"67","author":"Vasquez","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.preteyeres.2026.101460_bib328","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib329","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bjo.73.6.419","article-title":"Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes","volume":"73","author":"Villumsen","year":"1989","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11351","article-title":"Rapid induction of inflammatory lipid mediators by the inflammasome in vivo","volume":"490","author":"von Moltke","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101460_bib331","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201555","article-title":"Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer's model","volume":"5","author":"Wallace","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.preteyeres.2026.101460_bib332","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1755-3768.2009.01765.x","article-title":"Cyclooxygenase-2 expression in the normal human eye and its expression pattern in selected eye tumours","volume":"89","author":"Wang","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib333","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00125-018-4755-3","article-title":"Prostaglandin E(2)\/EP(2) receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes","volume":"62","author":"Wang","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.preteyeres.2026.101460_bib334","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","article-title":"MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109068","article-title":"Neurodegeneration with brain iron accumulation: insights into the mitochondria dysregulation","volume":"118","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101460_bib336","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13024-025-00858-5","article-title":"Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies","volume":"20","author":"Ward","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.preteyeres.2026.101460_bib337","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0090-6980(02)00044-8","article-title":"Prostaglandin F synthase","volume":"68\u201369","author":"Watanabe","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.preteyeres.2026.101460_bib338","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2026.101460_bib339","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-8703(03)00398-3","article-title":"Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program","volume":"146","author":"Weir","year":"2003","journal-title":"Am. Heart J."},{"key":"10.1016\/j.preteyeres.2026.101460_bib340","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","article-title":"The molecular basis of G protein-coupled receptor activation","volume":"87","author":"Weis","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib341","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1073\/pnas.85.2.304","article-title":"Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans","volume":"85","author":"Wendelborn","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101460_bib342","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.02-0392","article-title":"COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity","volume":"44","author":"Wilkinson-Berka","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib343","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/1060028015574593","article-title":"Comparing the efficacy of ophthalmic NSAIDs in common indications: a literature review to support cost-effective prescribing","volume":"49","author":"Wilson","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.preteyeres.2026.101460_bib344","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1523\/JNEUROSCI.0410-14.2014","article-title":"Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling","volume":"34","author":"Woodling","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib345","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.exer.2009.05.008","article-title":"Expression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina","volume":"89","author":"Wright","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib346","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2008.10.008","article-title":"Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist","volume":"88","author":"Wright","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib347","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neulet.2007.05.055","article-title":"Divergent effects of prostaglandin receptor signaling on neuronal survival","volume":"421","author":"Wu","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.preteyeres.2026.101460_bib348","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-8-22","article-title":"Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain","volume":"8","author":"Wu","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib349","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.str.2008.09.007","article-title":"Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2","volume":"16","author":"Wu","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.preteyeres.2026.101460_bib350","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbrc.2018.12.049","article-title":"The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion","volume":"508","author":"Xia","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib351","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1038\/s41467-025-63615-8","article-title":"Structure and transport mechanism of the human prostaglandin transporter SLCO2A1","volume":"16","author":"Xia","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108507","article-title":"Prostaglandin E(2) promotes pathological retinal neovascularisation via EP(4)R-EGFR-Gab1-AKT signaling pathway","volume":"205","author":"Xie","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib353","article-title":"A systematic analysis of genotype-phenotype associations with PLA2G6","volume":"112","author":"Xue","year":"2023","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.preteyeres.2026.101460_bib354","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1007\/s12035-015-9355-3","article-title":"Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system","volume":"53","author":"Yagami","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.preteyeres.2026.101460_bib355","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29273-1","article-title":"Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension","volume":"8","author":"Yamagishi-Kimura","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101460_bib356","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/iovs.63.2.24","article-title":"The roles played by FP\/EP3 receptors during pressure-lowering in mouse eyes mediated by a dual FP\/EP3 receptor agonist","volume":"63","author":"Yamagishi-Kimura","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib357","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2967\/jnumed.124.268525","article-title":"PET quantification in healthy humans of Cyclooxygenase-2, a potential biomarker of neuroinflammation","volume":"66","author":"Yan","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib358","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12974-020-01993-0","article-title":"Cyclooxygenase-1 mediates neuroinflammation and neurotoxicity in a mouse model of retinitis pigmentosa","volume":"17","author":"Yang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2026.101460_bib359","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1167\/iovs.09-3652","article-title":"The role of PGE2 receptor EP4 in pathologic ocular angiogenesis","volume":"50","author":"Yanni","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101460_bib360","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2337\/db23-0368","article-title":"Specialized retinal endothelial cells modulate blood-retina barrier in diabetic retinopathy","volume":"73","author":"Yao","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2026.101460_bib361","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2010.10.019","article-title":"Preferential localization of prostamide\/prostaglandin F synthase in myelin sheaths of the central nervous system","volume":"1367","author":"Yoshikawa","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib362","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41232-024-00343-4","article-title":"CX3CL1-CX3CR1 axis protects retinal ganglion cells by inhibiting microglia activation in a distal optic nerve trauma model","volume":"44","author":"Yu","year":"2024","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.preteyeres.2026.101460_bib363","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1074\/jbc.M114.632463","article-title":"A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus","volume":"290","author":"Yuan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib364","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12964-022-00973-6","article-title":"PGE(2) promotes macrophage recruitment and neovascularization in murine wet-type AMD models","volume":"20","author":"Zhan","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.preteyeres.2026.101460_bib365","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45881","article-title":"Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse","volume":"8","author":"Zhang","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.preteyeres.2026.101460_bib366","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1046\/j.1471-4159.2000.0742134.x","article-title":"A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta","volume":"74","author":"Zhang","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2026.101460_bib367","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108799","article-title":"Altered oxylipin levels in human vitreous indicate imbalance in pro-\/anti-inflammatory homeostasis in proliferative diabetic retinopathy","volume":"214","author":"Zhao","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101460_bib368","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2015.02.011","article-title":"Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice","volume":"46","author":"Zhao","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.preteyeres.2026.101460_bib369","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216373","article-title":"PGF(2alpha) facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR(+) CXC chemokine expression","volume":"15","author":"Zhao","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib370","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1186\/s12967-024-05654-1","article-title":"Indoxyl sulfate induces retinal microvascular injury via COX-2\/PGE(2) activation in diabetic retinopathy","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101460_bib371","article-title":"Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:22:56Z","timestamp":1779510176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946226000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":371,"alternative-id":["S1350946226000261"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101460","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of prostanoids in the retina and optic nerve in health and disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101460"}}